Interaction Check

This page cannot be displayed because your browser has been configured to disable JavaScript, also known as "Active Scripting".Please change your settings and refresh the page.

Sign in to access our clinical decision support tools

Sign in Create Account

Selected Drugs Clear All

MultiCheck Results - 5 Interactions

Caution Advised
Aptiom (eslicarbazepine acetate) + Lamictal ODT (lamotrigine)
Caution Advised eslicarbazepine acetate + lamotrigine caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)
Aptiom (eslicarbazepine acetate) + Spritam (levetiracetam)
Caution Advised eslicarbazepine acetate + levetiracetam caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)
Aptiom (eslicarbazepine acetate) + Subvenite (lamotrigine)
Caution Advised eslicarbazepine acetate + lamotrigine caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)
Lamictal ODT (lamotrigine) + Spritam (levetiracetam)
Caution Advised lamotrigine + levetiracetam caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)
Spritam (levetiracetam) + Subvenite (lamotrigine)
Caution Advised levetiracetam + lamotrigine caution advised: combo may incr. risk of CNS depression, psychomotor impairment (additive effects)
Additional Considerations
lamotrigine in Lamictal ODT, Subvenite
caution advised with other sodium channel blockers; combo may increase risk of ECG changes, cardiac arrhythmias; additive effects